General practitioner prescribing trends among pediatric patients in the United Kingdom: 1998-2018

Reem Masarwa1,2, Claire Lefebvre3, Robert W Platt1,2,4

  • 1Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.

Insights

Pediatric prescribing trends show increased use of ADHD and GERD medications, alongside decreased use of cough preparations and analgesics. Systemic antibiotic prescribing remained stable.

Area of Science:

  • Pediatric pharmacology
  • Drug utilization research
  • Public health

Background:

  • Understanding pediatric prescribing patterns is crucial for optimizing child health outcomes.
  • Long-term trends in medication use among children and adolescents require continuous monitoring.
  • Previous studies have indicated shifts in prescribing habits, necessitating updated analyses.

Purpose of the Study:

  • To analyze prescribing trends for 17 therapeutic drug categories in UK children and adolescents from 1998 to 2018.
  • To specifically examine changes in the use of systemic antibiotics, analgesics, and antidepressants.
  • To identify significant shifts in pediatric medication utilization over a 20-year period.

Main Methods:

  • A retrospective cohort study utilizing UK population data from 1998 to 2018.
  • Inclusion of children and adolescents aged 0-18 years.
  • Calculation of prescription rates per 10,000 person-years and analysis of changes using Poisson regression.

Main Results:

  • Prescribing rates increased for attention deficit hyperactivity disorder (ADHD) drugs (+15%), anxiolytics/hypnotics (+14%), and gastroesophageal reflux disease (GERD) drugs (+8%).
  • Prescribing rates decreased for cough preparations (-6%) and analgesics (-3%).
  • No significant changes were observed for systemic antibiotics; however, specific classes showed shifts, with increased use of SSRIs and opioids, and decreased use of broad-spectrum penicillins.

Conclusions:

  • Central nervous system medications and GERD treatments saw increased prescribing in pediatric populations.
  • A decline in the use of cough preparations and analgesics was observed in children and adolescents.
  • These findings highlight evolving patterns in pediatric pharmacotherapy, emphasizing the need for ongoing surveillance.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
23
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
29
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
37
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
33
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
25
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
906